- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Taiwanese Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
16
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
16 companies
Synmosa Biopharma
Market Cap: NT$13.1b
A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.
4114
NT$31.20
7D
7.2%
1Y
-10.3%
HeXun Biosciences
Market Cap: NT$3.5b
Engages in the research and development of stem cell and treatments in Taiwan.
6986
NT$75.40
7D
8.3%
1Y
7.7%
Orient Pharma
Market Cap: NT$6.4b
Engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally.
4166
NT$28.50
7D
10.3%
1Y
23.1%
Savior Lifetec
Market Cap: NT$5.6b
A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.
4167
NT$17.65
7D
22.1%
1Y
-20.0%
Maxigen Biotech
Market Cap: NT$3.7b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$41.20
7D
14.1%
1Y
-6.4%
YungShin Global Holding
Market Cap: NT$17.8b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$66.70
7D
23.1%
1Y
38.5%
Sunmax Biotechnology
Market Cap: NT$22.7b
A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
4728
NT$417.00
7D
22.3%
1Y
84.5%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.9b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$88.10
7D
7.4%
1Y
7.4%
ScinoPharm Taiwan
Market Cap: NT$14.4b
Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.
1789
NT$18.20
7D
9.3%
1Y
-34.4%
Ever Supreme Bio Technology
Market Cap: NT$13.7b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells.
6712
NT$167.50
7D
16.3%
1Y
-10.6%
Panion & Bf Biotech
Market Cap: NT$5.7b
A biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally.
1760
NT$66.10
7D
18.0%
1Y
-35.5%
TTY Biopharm
Market Cap: NT$18.2b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$73.20
7D
9.3%
1Y
-5.1%
SCI Pharmtech
Market Cap: NT$8.5b
Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.
4119
NT$71.20
7D
7.6%
1Y
-19.5%
Formosa Laboratories
Market Cap: NT$7.1b
Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.
4746
NT$59.00
7D
19.2%
1Y
-44.1%
Nang Kuang Pharmaceutical
Market Cap: NT$3.6b
Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.
1752
NT$35.50
7D
16.0%
1Y
-21.3%
PharmaEngine
Market Cap: NT$12.5b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$87.10
7D
13.9%
1Y
-5.9%